Eledon raises ~$46.5M in public offering of common stock and pre-funded warrants

Eledon Pharmaceuticals, Inc.

Underwritten offering of 15.15M shares at $1.65/share and up to 15.15M pre-funded warrants at $1.649/warrant.
Net proceeds estimated at $46.5M; up to $53.6M if underwriters' 30-day option is fully exercised.
Proceeds to fund clinical development of product candidates and for general corporate purposes.
Underwriters granted 30-day option to purchase up to 4.55M additional shares of common stock.
Company and certain insiders subject to 60-day lock-up on sales of securities.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.